About the Journal

The Journal of Cancer and Translational Oncology (JCTO) is an international, peer-reviewed, open-access scholarly journal dedicated to advancing research in oncology, cancer biology, and translational medicine. The journal serves as a global platform for researchers, clinicians, and healthcare professionals to publish and access high-quality scientific work focused on understanding cancer mechanisms and improving patient care outcomes.

The journal emphasizes the critical link between laboratory-based discoveries and clinical applications, with a strong focus on translational research that accelerates the development of innovative diagnostic tools, therapeutic strategies, and personalized treatment approaches in oncology.

The Journal of Cancer and Translational Oncology welcomes original research articles, clinical studies, review papers, and emerging innovations across all areas of cancer research. It particularly encourages interdisciplinary work that integrates molecular oncology, cancer genetics, immunology, pharmacology, biotechnology, and clinical medicine.

Key focus areas include, but are not limited to:

  • Molecular and Cellular Oncology

  • Cancer Genetics and Epigenetics

  • Tumor Immunology and Immunotherapy

  • Targeted Cancer Therapies

  • Precision and Personalized Medicine

  • Cancer Biomarkers and Diagnostics

  • Clinical Oncology and Clinical Trials

  • Radiation and Chemotherapy Research

  • Cancer Prevention and Early Detection

  • Translational Cancer Research

  • Bioinformatics and Computational Oncology

  • Drug Development and Experimental Therapeutics

The journal promotes the rapid dissemination of scientific knowledge by providing unrestricted open access to all published content, ensuring that research findings are freely available to the global scientific and medical community without subscription barriers.

All accepted manuscripts undergo a rigorous peer-review process to ensure scientific validity, originality, and clinical relevance. Published articles are permanently archived in PDF format to ensure long-term accessibility and preservation.

Through its commitment to ethical publishing, scientific excellence, and translational innovation, the Journal of Cancer and Translational Oncology aims to contribute significantly to the advancement of cancer research and the improvement of patient outcomes worldwide.